ACLARION, INC. Shares Authorized
ACLARION, INC. (ACON) had Shares Authorized of 200.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares Authorized 200.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 200.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 200.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 200.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 200.00M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 200.00M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 200.00M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 200.00M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 200.00M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 200.00M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 200.00M shares 10-K · filed 2026-03-18 | |
| 2024-09-30 | 200.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 200.00M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 200.00M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 200.00M shares 10-K · filed 2025-04-09 | |
| 2023-09-30 | 200.00M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 200.00M shares 10-Q · filed 2023-08-25 | |
| 2023-03-31 | 200.00M shares 10-Q · filed 2023-07-03 | |
| 2022-12-31 | 200.00M shares 10-K · filed 2024-03-28 | |
| 2022-09-30 | 200.00M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 200.00M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 35.00M shares 10-Q · filed 2022-06-06 | |
| 2021-12-31 | 200.00M shares 10-K/A · filed 2023-06-12 | 35.00M shares 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |